Managing unexpected events in the manufacturing of biologic medicines.
about
Oncolytic viruses: a new class of immunotherapy drugs.Implementing high-temperature short-time media treatment in commercial-scale cell culture manufacturing processes.Manufacturing history of etanercept (Enbrel®): Consistency of product quality through major process revisions.Preventing shortages of biologic medicines.
P2860
Managing unexpected events in the manufacturing of biologic medicines.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Managing unexpected events in the manufacturing of biologic medicines.
@en
type
label
Managing unexpected events in the manufacturing of biologic medicines.
@en
prefLabel
Managing unexpected events in the manufacturing of biologic medicines.
@en
P2860
P1433
P1476
Managing unexpected events in the manufacturing of biologic medicines.
@en
P2093
Gustavo Grampp
Sundar Ramanan
P2860
P2888
P304
P356
10.1007/S40259-013-0018-5
P577
2013-08-01T00:00:00Z